EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial

Anselm Jorda, Lena Pracher, Sabine Eberl, Alina Nussbaumer-Pröll, Maysa Sarhan, Maria Weber, Markus Wahrmann, Valentin Al Jalali, Felix Bergmann, Marlene Prager, Amelie Leutzendorff, Maria Sanz-Codina und 10 weitere

Medical Microbiology and Immunology · 2025

DOI: 10.1007/s00430-025-00823-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Microbiology and Immunology, 2025. Verfasst von Anselm Jorda und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria. Hauptthemen laut MEDLINE: Lipopolysaccharides, Cytokines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whether the magnitude of individual cytokine, cellular, and clinical responses to the intravenous lipopolysaccharide (LPS) challenge is constant in individuals over extended time periods is unknown. Nine healthy volunteers received an intravenous LPS injection of 2 ng/kg bodyweight twice at intervals of at least one year. Circulating cytokines and leukocyte subsets were quantified using a multiplex immunoassay and cytometry by time-of-flight, respectively. Self-reported symptoms and vital signs were also assessed. We observed moderate to strong intra-individual correlations in the responsiveness of most cytokines (IL-6 [AUC 0 − 10 ]: R = 0.93, p < 0.001; CRP [mg/dL]: R = 0.88, p = 0.004; IL-8 [AUC 0 − 10 ]: R = 0.71, p = 0.031; TNF-alpha [AUC 0 − 10 ]: R = 0.67, p = 0.047; IL-10 [AUC 0 − 10 ]: R = 0.42, p = 0.26) and cellular subsets (CD8 T lymphocytes: R = 0.9, p = 0.002; B lymphocytes [G/L]: R = 0.89, p = 0.003; CD4 T lymphocytes: R = 0.84, p = 0.001; neutrophils: R = 0.80, p = 0.017; monocytes: R = 0.16, p = 0.710) between the 1st and 2nd LPS challenges. Vital signs and symptoms were not reproducible. While the average cellular and clinical response was similar between the two LPS challenges, we found a significantly attenuated AUC 0 − 10 of IL-6 (percent difference, -41.9% [95% CI -73.0 – -10.7]) and TNF-alpha (percent difference, -35.7% [95% CI -70.0 – -1.6]) at the 2nd LPS challenge. Individual cytokine and cellular responses to intravenous LPS showed a significant degree of correlation when measured more than one year apart. These correlations did not translate to the reproducibility of clinical symptoms and vital signs, which showed greater variability and were not constant over time. The partly reduced cytokine release in the 2nd LPS challenge might be interpreted as an indicator of a long-lasting tolerance to endotoxin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesCytokinesHumansMaleAdultHealthy VolunteersFemaleYoung AdultMiddle Aged

Stichwörter der Autor:innen

EndotoxemiaEndotoxinInflammationInnate immune systemSepsis

Substanzen

LipopolysaccharidesCytokines

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
  • Division of Nephrology and Dialysis, Department of Internal Medicine III, Vienna, Austria.
  • Division of Infectious Diseases and Tropical Medicine, Department of Medicine III, Vienna, Austria.
  • Core Facilities, Medical University of Vienna, Vienna, Austria.
  • Research Laboratories, Core Facility Flow Cytometry & Department of Surgery, Medical University of Vienna, Vienna, Austria.
  • Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.

Förderung

  • Medical University of Vienna

Zitieren

APA

Jorda, A., Pracher, L., Eberl, S., Nussbaumer-Pröll, A., Sarhan, M., Weber, M., Wahrmann, M., Al Jalali, V., Bergmann, F., Prager, M., Leutzendorff, A., Sanz-Codina, M., Tegrovsky, L., Pecho, T., Jilma, B., Müller, L., Spittler, A., Rocha-Hasler, M., Eckl-Dorna, J., …, & Zeitlinger, M. (2025). Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial. Medical Microbiology and Immunology. https://doi.org/10.1007/s00430-025-00823-5

Vancouver

Jorda A, Pracher L, Eberl S, Nussbaumer-Pröll A, Sarhan M, Weber M, et al. Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial. Medical Microbiology and Immunology. 2025. doi:10.1007/s00430-025-00823-5

BibTeX
@article{Jorda2025,
  author = {Jorda, Anselm and Pracher, Lena and Eberl, Sabine and Nussbaumer-Pröll, Alina and Sarhan, Maysa and Weber, Maria and Wahrmann, Markus and Al Jalali, Valentin and Bergmann, Felix and Prager, Marlene and Leutzendorff, Amelie and Sanz-Codina, Maria and Tegrovsky, Lara and Pecho, Theresa and Jilma, Bernd and Müller, Lena and Spittler, Andreas and Rocha-Hasler, Marianne and Eckl-Dorna, Julia and Kusienicka, Anna and Farlik, Matthias and Zeitlinger, Markus},
  title = {Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial},
  journal = {Medical Microbiology and Immunology},
  year = {2025},
  doi = {10.1007/s00430-025-00823-5}
}
Kostenlos starten →